Vitamin D supplements' potency varies widely
The amount of vitamin D in supplements can be anything from 9% to 146% of the stated dose, according to a research letter published in the JAMA Internal Medicine.1
The amount of vitamin D in supplements can be anything from 9% to 146% of the stated dose, according to a research letter published in the JAMA Internal Medicine.1 Investigators from Kaiser Permanente (Portland, Oregon, USA) tested 55 bottles of over-the-counter vitamin D supplement tablets from 12 different manufacturers using high performance liquid chromatography (HPLC).
Vitamin D supplements are often prescribed for vitamin D deficiencies, but are not regulated by the Food and Drug Administration (FDA). There are a range of reports suggesting that a vitamin D deficiency may have links to a number of health problems from neurological disorders to hypertension, as reported in The Column2 last year. Hypovitaminosis D, a deficiency of vitamin D from either dietary or sunlight sources, is now widely recognized to be an affliction of the western world as a result of low sunlight exposure and poor diet.
Supplement tablets purchased from Portland pharmacies were analysed by HPLC and found to contain 9–146% of the labeled concentration. This variation was found not only between tablets produced by manufacturers but also between tablets contained within the same bottle.
“We were surprised by the variation in potency among these vitamin D pills,” said study co-author Erin LeBlanc, lead author and investigator, Kaiser Permanente Center for Health Research (Portland, Oregon, USA). “The biggest worry is for someone who has low levels of vitamin D in their blood. If they are consistently taking a supplement with little vitamin D in it, they could face health risks.”
Manufacturers can voluntarily submit supplements to accreditation by US Pharmacopeial Standards (USP). These standards require tablets to contain between 90% and 110% active ingredient. According to the report, these may be sparsely distributed.
“The USP verification mark may give consumers some reassurance that the amount of vitamin D in those pills is close to the amount listed on the label”, commented LeBlanc. “There are not many manufacturers that have the USP mark, but it may be worth theextra effort to look for it.”
References
1. E.S. LeBlanc, N. Perrin, J. Johnson Jr, A. Ballatore and T. Hiller, JAMA Intern. Med., DOI: 10.1001/jamainternmed.2013.3812 (2013).
2. Vitamin D detection, The Column 20(8) 6 (2012) http://www.chromatographyonline.com/lcgc/article/articleDetail.jsp?id=796682&sk=ea1ac8c2df2bd242b00772da76a994d8
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
